SOURCE: Sunesis Pharmaceuticals

Sunesis Pharmaceuticals

March 01, 2010 07:30 ET

Sunesis to Present at Upcoming Healthcare Conferences

SOUTH SAN FRANCISCO, CA--(Marketwire - March 1, 2010) - Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced that the Company is scheduled to participate in the following events in March:

  • RBC Capital Markets 2010 Healthcare Conference
    Panel: "Cancer: Improving Treatment through Combination Therapy"
    Wednesday, March 3, 2010 at 8:00 a.m. Eastern Time at the New York Palace Hotel in New York City;

  • Cowen and Company 30th Annual Healthcare Conference
    Wednesday, March 10, 2010 at 8:45 a.m. Eastern Time at the Boston Marriott Copley Place Hotel in Boston.

Live webcasts of the events will be available on the Sunesis website at A replay of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks following the respective dates of the presentations.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.

Contact Information

  • Investor and Media Inquiries:
    Andrea Rabney
    Argot Partners

    Eric Bjerkholt
    Sunesis Pharmaceuticals Inc.